Kinnate Biopharma Inc.

NASDAQ:KNTE

2.65 (USD) • At close April 2, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q4
Omzet 00000000000000000
Kosten van de omzet 0.1980.1970.2010.2030.190.1840.1720000000000
Brutowinst -0.198-0.197-0.201-0.203-0.19-0.184-0.1720000000000
Brutowinstmarge 00000000000000000
Onderzoek- en ontwikkelingskosten 13.3724.51126.32726.55925.18823.54819.76719.64719.52918.72916.24212.66611.9768.4845.5793.1983.059
Algemene en administratieve kosten 5.7346.6057.8088.0947.4967.8247.6397.4126.736.0735.3274.8151.7432.0192.0470.9550.926
Verkoop- en marketingkosten -0.1980000000000000000
Verkoop-, algemene en administratieve kosten 5.5366.6057.8088.0947.4967.8247.6397.4126.736.0735.3274.8151.7432.0192.0470.9550.926
Overige kosten 2.2411.9732.2171.7131.1210.6350.3370.1570-0.54-0.548-0.3792.0470000
Bedrijfskosten 18.90633.08934.13534.65332.68431.37227.40627.05926.25924.80221.56917.48113.71910.5037.6264.1533.985
Bedrijfsresultaat -19.104-33.089-34.135-34.653-32.684-31.372-27.406-27.059-26.259-24.802-21.569-17.481-13.719-10.503-7.626-4.153-3.985
Bedrijfsresultaat ratio 00000000000000000
Totaal overige inkomsten en kosten netto 2.0462.3562.2171.7131.1210.6350.3370.1570.10.10.1240.0240.0120.0040.0120.2120.043
Inkomen voor belasting -17.058-30.733-31.918-32.94-31.563-30.737-27.069-26.902-26.159-24.702-21.445-17.457-13.707-10.499-7.614-3.941-3.942
Inkomen voor belasting ratio 00000000000000000
Belastingkosten 0-0.1970-1.713-1.615-0.635-0.337-0.1570.012-0.64-0.672-0.40300000
Nettowinst -17.058-30.733-31.918-31.227-29.948-30.102-26.732-26.745-26.159-24.702-21.445-17.457-13.707-10.499-7.614-3.941-3.942
Nettowinstmarge 00000000000000000
WPA (Winst Per Aandeel) -0.36-0.65-0.68-0.69-0.68-0.68-0.61-0.61-0.6-0.57-0.49-0.4-0.31-0.26-0.33-0.17-0.091
Verwaterde WPA -0.36-0.65-0.68-0.69-0.68-0.68-0.61-0.61-0.6-0.57-0.49-0.4-0.31-0.26-0.33-0.17-0.091
EBITDA -18.906-33.089-33.934-34.45-32.494-31.188-27.234-27.001-26.223-24.774-21.541-17.45-13.695-10.48-7.606-4.137-3.985
EBITDA ratio 00000000000000000